glp-1 agonist benefits glp 1 used for weight loss Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Part 3 of a 3-Part

Evidence from both preclinical and clinical studies supports their antiinflammatory roles in the cardiovascular system, liver, kidneys, and joints

They are approved only for type 2 diabetes management and, for specific agents like semaglutide (Wegovy) and liraglutide (Saxenda), chronic weight management in adults with obesity or overweight with comorbidities

2.2 The role of GLP-1 in innate-like T lymphocytes Invariant Natural Killer T (iNKT) cells are a subpopulation of T lymphocytes that bridge the innate and adaptive immune systems (40)

Major players including Novo Nordisk and Eli Lilly maintain substantial commercial footprints, competing aggressively on efficacy claims, patient support programs, and contracting strategies

Conversely, patients with long-standing obesity, multiple previous weight loss attempts, or significant metabolic dysfunction may benefit from indefinite therapy